Intravenous tranexamic acid for intracerebral meningioma resections: A randomized, parallel-group, non-inferiority trial.

[1]  O. Hershkovich,et al.  Intravenous Tranexamic Acid Reduces Blood Loss in Multilevel Spine Surgeries , 2022, The Journal of the American Academy of Orthopaedic Surgeons.

[2]  Hansong Sun,et al.  Effect of High- vs Low-Dose Tranexamic Acid Infusion on Need for Red Blood Cell Transfusion and Adverse Events in Patients Undergoing Cardiac Surgery: The OPTIMAL Randomized Clinical Trial. , 2022, JAMA.

[3]  W. Boling,et al.  Meningioma Related Epilepsy- Pathophysiology, Pre/postoperative Seizures Predicators and Treatment , 2022, Frontiers in Oncology.

[4]  T. Horiuchi,et al.  The Occurrence and Relationship of Postoperative Seizure and de novo Epilepsy after Craniotomy Surgery: A Retrospective Single-Center Cohort Study , 2022, Frontiers in Surgery.

[5]  Pavel S. Roshanov,et al.  Tranexamic Acid in Patients Undergoing Noncardiac Surgery. , 2022, The New England journal of medicine.

[6]  Yuming Peng,et al.  Safety of intravenous tranexamic acid in patients undergoing supratentorial meningiomas resection: protocol for a randomised, parallel-group, placebo control, non-inferiority trial , 2022, BMJ Open.

[7]  Lei Wang,et al.  Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery , 2022, Therapeutic advances in neurological disorders.

[8]  I. Roberts,et al.  Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: a systematic review and meta-analysis , 2021, Critical Care.

[9]  P. Wen,et al.  SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. , 2021, Neuro-oncology.

[10]  Mohamed Aziz Daghmouri,et al.  Intraoperative tranexamic acid use in patients undergoing excision of intracranial meningioma: Randomized, placebo-controlled trial , 2021, Surgical neurology international.

[11]  J. Ahluwalia,et al.  Effect of tranexamic acid on blood loss, coagulation profile, and quality of surgical field in intracranial meningioma resection: A prospective randomized, double-blind, placebo-controlled study , 2021, Surgical neurology international.

[12]  S. Mittal,et al.  Pathogenesis and Management of Brain Tumor-Related Epilepsy , 2021, Gliomas.

[13]  V. Nikolaou,et al.  Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial. , 2021, The Bone & Joint Journal.

[14]  Wenxiao Xu,et al.  Role of tranexamic acid in blood loss control and blood transfusion management of patients undergoing multilevel spine surgery , 2021, Medicine.

[15]  E. Cole,et al.  The impact of prehospital TXA on mortality among bleeding trauma patients: A systematic review and meta-analysis , 2021, The journal of trauma and acute care surgery.

[16]  Zhen Wu,et al.  Surgical outcomes and prognostic factors of parasagittal meningioma: a single-center experience 165 consecutive cases , 2021, British journal of neurosurgery.

[17]  H. Vatter,et al.  Preoperative tumor-associated epilepsy in patients with supratentorial meningioma: factors influencing seizure outcome after meningioma surgery. , 2020, Journal of neurosurgery.

[18]  I. Roberts,et al.  Pharmacokinetics of intramuscular tranexamic acid in bleeding trauma patients: a clinical trial. , 2020, British journal of anaesthesia.

[19]  R. Coras,et al.  Early postoperative seizures (EPS) in patients undergoing brain tumour surgery , 2020, Scientific Reports.

[20]  N. Rabelo,et al.  Tranexamic acid in Neurosurgery: a controversy indication—review , 2020, Neurosurgical Review.

[21]  A. Marson,et al.  Antiepileptic drugs as prophylaxis for postcraniotomy seizures. , 2020, The Cochrane database of systematic reviews.

[22]  M. Heyns,et al.  A Single Preoperative Dose of Tranexamic Acid Reduces Perioperative Blood Loss , 2020, Annals of surgery.

[23]  I. Roberts,et al.  Tranexamic acid through intravenous, intramuscular and oral routes: an individual participant data meta‐analysis of pharmacokinetic studies in healthy volunteers , 2019, Fundamental & clinical pharmacology.

[24]  P. Gambús,et al.  Perioperative blood loss: estimation of blood volume loss or haemoglobin mass loss? , 2019, Blood transfusion = Trasfusione del sangue.

[25]  R. Matthews,et al.  Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial , 2019, The Lancet.

[26]  S. Pocock,et al.  Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT. , 2019, Health Technology Assessment.

[27]  P. Qiu,et al.  Characteristic features and proposed classification in 69 cases of intracranial microcystic meningiomas , 2019, Neurosurgical Review.

[28]  C. Yun,et al.  Risk factors for preoperative and late postoperative seizures in primary supratentorial meningiomas , 2019, Clinical Neurology and Neurosurgery.

[29]  E. Wood,et al.  Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference , 2019, JAMA.

[30]  X. Ren,et al.  Risk factors and control of seizures in 778 Chinese patients undergoing initial resection of supratentorial meningiomas , 2019, Neurosurgical Review.

[31]  I. Roberts,et al.  What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies , 2019, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[32]  A. Vilaseca,et al.  Agreement of surgical blood loss estimation methods , 2018, Transfusion.

[33]  S. Pocock,et al.  Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial , 2018, The Lancet.

[34]  R. Rowell,et al.  Review: Molecular characteristics of long‐term epilepsy‐associated tumours (LEATs) and mechanisms for tumour‐related epilepsy (TRE) , 2018, Neuropathology and applied neurobiology.

[35]  W. Broaddus,et al.  A systematic review of perioperative seizure prophylaxis during brain tumor resection: the case for a multicenter randomized clinical trial. , 2017, Neurosurgical focus.

[36]  Dario J. Englot,et al.  Factors Associated With Pre- and Postoperative Seizures in 1033 Patients Undergoing Supratentorial Meningioma Resection , 2017, Neurosurgery.

[37]  Bhavna Hooda,et al.  Effect of tranexamic acid on intraoperative blood loss and transfusion requirements in patients undergoing excision of intracranial meningioma , 2017, Journal of clinical neuroscience.

[38]  A. López-Picado,et al.  Determination of Perioperative Blood Loss: Accuracy or Approximation? , 2017, Anesthesia and analgesia.

[39]  J. H. Cross,et al.  Instruction manual for the ILAE 2017 operational classification of seizure types , 2017, Epilepsia.

[40]  J. Mikler,et al.  Comparison of tranexamic acid plasma concentrations when administered via intraosseous and intravenous routes☆ , 2017, The American journal of emergency medicine.

[41]  M. Weller,et al.  Predicting outcome of epilepsy after meningioma resection. , 2016, Neuro-oncology.

[42]  Xiaoyi Zou,et al.  Tranexamic acid-associated seizures: A meta-analysis , 2016, Seizure.

[43]  A. Flexman,et al.  Use of Tranexamic Acid Is Associated with Reduced Blood Product Transfusion in Complex Skull Base Neurosurgical Procedures: A Retrospective Cohort Study , 2016, Anesthesia and analgesia.

[44]  B. Orser,et al.  Tranexamic acid–associated seizures: Causes and treatment , 2015, Annals of neurology.

[45]  S. Mishra,et al.  Effect of low dose tranexamic acid on intra-operative blood loss in neurosurgical patients , 2015, Saudi journal of anaesthesia.

[46]  Song Lin,et al.  Surgical management of meningioma of the trigone area of the lateral ventricle. , 2014, World neurosurgery.

[47]  A. Levin,et al.  Practice Guideline , 2020, Encyclopedia of Behavioral Medicine.

[48]  S. Warach,et al.  Blood-Brain Barrier Disruption after Cardiac Surgery , 2013, American Journal of Neuroradiology.

[49]  B. Orser,et al.  Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. , 2012, The Journal of clinical investigation.

[50]  X. Capdevila,et al.  Intraoperative Tranexamic Acid Reduces Blood Transfusion in Children Undergoing Craniosynostosis Surgery: A Randomized Double-blind Study , 2011, Anesthesiology.

[51]  W. Sieghart,et al.  Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid(A) receptor antagonistic effect. , 2002, The Journal of pharmacology and experimental therapeutics.

[52]  A. Nimmo,et al.  Association of Anaesthetists guidelines: cell salvage for peri‐operative blood conservation 2018 , 2018, Anaesthesia.

[53]  A. Menkis,et al.  Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors , 2011, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.